23 results on '"Díez O"'
Search Results
2. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
3. Abstract P6-06-03: Withdrawn
4. Lack of RAD51 foci formation enables the identification of PARP inhibitor sensitive breast tumors
5. Lurbinectedin (PM01183) exhibits antitumor activity in PARP-inhibitor resistant germline BRCA PDX and lacks cross-resistance with cisplatin
6. Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics
7. BRCA in breast cancer: ESMO Clinical Practice Guidelines
8. 3532 POSTER Uptake of Prophylactic Mastectomy And/or Salpingo-ophorectomy Among Spanish BRCA Mutation Carriers
9. High prevalence of BRCA1/2 germline mutations in female breast cancer patients with triple-negative phenotype (TNBC) and family history.
10. Preliminary Results of the Mutational Analysis of the TP53 Gene in Women Diagnosed with Breast Cancer before the Age of 35 Years and Negative for BRCA1 and BRCA2 Mutations.
11. BRCA2 splice site mutations in an Italian breast/ovarian cancer family
12. BRCA in breast cancer: ESMO Clinical Recommendations
13. A reversed-phase ion-interaction chromatographic method for in-vitro estimation of the percutaneous absorption of water-soluble UV filters
14. An Equation for the Correlation of Viscosities of Binary Mixtures
15. A liquid chromatography–fluorimetric method for the in vitro estimation of the skin penetration of disodium phenyldibenzimidazole tetrasulfonate from sunscreen formulations through human skin
16. A haplotype containing thep53polymorphisms Ins16bp and Arg72Pro modifies cancer risk inBRCA2mutation carriers
17. Concentraciones de colesterol, alfa -tocoferol y retinoides en aceite de silicona tras su utilizaciσn como sustitutivo vνtreo
18. Is genetic testing being performed by the proband's close relatives? An assessment in hereditary breast and ovarian cancer (HBOC) Spanish families
19. Is genetic testing being performed by the proband's close relatives? An assessment in hereditary breast and ovarian cancer (HBOC) Spanish families
20. BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families
21. Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up
22. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
23. Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.